Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients.

@article{Rourke2010ReviewOC,
  title={Review of clinical trials conducted in Waldenstrom macroglobulinemia and recommendations for reporting clinical trial responses in these patients.},
  author={Meghan A. Rourke and Kenneth C. Anderson and Irene M Ghobrial},
  journal={Leukemia & lymphoma},
  year={2010},
  volume={51 10},
  pages={1779-92}
}
Many novel therapeutic agents are being tested in clinical trials for Waldenstrom macroglobulinemia (WM). However, given the paucity of large clinical trials in WM, the establishment of a standard treatment regimen that can be used for comparison of response has become challenging. We therefore performed a review of published clinical trials in WM. Systematic searches of the PubMed and Medline databases, including The Cochrane Library, were performed for the search terms: clinical trials… CONTINUE READING